A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
Stephen A. Harrison,Pierre Bedossa,Cynthia D. Guy,Joern M. Schattenberg,Rohit Loomba,Rebecca Taub,Dominic Labriola,Sam E. Moussa,Guy W. Neff,Mary E. Rinella,Quentin M. Anstee,Manal F. Abdelmalek,Zobair Younossi,Seth J. Baum,Sven Francque,Michael R. Charlton,Philip N. Newsome,Nicolas Lanthier,Ingolf Schiefke,Alessandra Mangia,Juan M. Pericas,Rashmee Patil,Arun J. Sanyal,Mazen Noureddin,Meena B. Bansal,Naim Alkhouri,Laurent Castera,Madhavi Rudraraju,Vlad Ratziu NEW ENGLAND JOURNAL OF MEDICINE（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper